Journal of shoulder and elbow surgery · 2025
Opioid consumption following isolated and recurrent shoulder dislocation and reduction.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Maheshwer Bhargavi, Chen Kallie J, Kuka Casey C, Halkiadakis Penelope, Raji Yazdan, Karns Michael R
Аннотация
BACKGROUND: Recurrent shoulder dislocations often lead to multiple encounters for reduction and eventual surgical stabilization, both of which involve exposure to opioids and potentially increase the risk of chronic opioid exposure. The purpose of our study was to characterize shoulder instability and compare pre- and postreduction opioid usage in singular dislocators (SDs) and recurrent dislocators (RDs).
METHODS: This retrospective study was performed at a single academic institution using a prospective database. Patients were included if they were (1) age 18 years or older and (2) sustained a shoulder dislocation evaluated within our institution. Electronic medical records were reviewed for patient demographics, emergency department management, and opioid exposure (number and mean morphine equivalent [MME] of opioid prescriptions) both pre- and postreduction. Cohorts were compared using Wilcoxon rank-sum tests for continuous variables and χ2 or Fisher exact tests for categorical variables, with statistical significance set at P < .05.
RESULTS: A total of 222 patients were included with mean follow-up 4.4 months (range: 0-70.1 months). Fifty-three patients (23.8%) sustained recurrent dislocations. RDs were significantly younger (median age 26.7 years, interquartile range [IQR]: 21.6-44.9) than SDs (55.3 years, IQR: 32.8-70.4; P < .001) and more likely to have sustained a prior shoulder fracture (n = 11 [21.2%] vs. n = 3 [1.8%], P < .001). There were no differences in sex, laterality, or follow-up duration. Eighteen RDs (34.0%) and 18 SDs (10.7%) underwent surgery, including shoulder stabilization procedures, rotator cuff repairs, and fracture fixation (P < .001). RDs used significantly more opioids at the first follow-up in both the prescribed number of opioids (mean 0.23 ± 0.5 prescriptions vs. 0.10 ± 0.3, P = .038) and MME (mean 38.3 ± 96.2 MME vs. 10.7 ± 66.4 MME, P = .013). This difference is not appreciated from the 30-day postoperative visit onward. Emergency room opioid MME prescription and consumption was similar between cohorts.
CONCLUSION: Patients who sustain recurrent shoulder dislocations exhibit a higher likelihood of consuming significantly greater amounts of opioids following shoulder reduction and ultimately undergoing surgical intervention. The proportion of opioid tolerance and prereduction total MME up to 90 days prior to reduction in the RD cohort trended toward significance, but there were no differences observed between rates of opioid usage during ED encounters or at the 30-, 60-, and 90-day time points. Patients with chronic shoulder instability should be counseled regarding the increased risk of opioid prescription patterns in the immediate postreduction period; however, this risk may decrease over time.
METHODS: This retrospective study was performed at a single academic institution using a prospective database. Patients were included if they were (1) age 18 years or older and (2) sustained a shoulder dislocation evaluated within our institution. Electronic medical records were reviewed for patient demographics, emergency department management, and opioid exposure (number and mean morphine equivalent [MME] of opioid prescriptions) both pre- and postreduction. Cohorts were compared using Wilcoxon rank-sum tests for continuous variables and χ2 or Fisher exact tests for categorical variables, with statistical significance set at P < .05.
RESULTS: A total of 222 patients were included with mean follow-up 4.4 months (range: 0-70.1 months). Fifty-three patients (23.8%) sustained recurrent dislocations. RDs were significantly younger (median age 26.7 years, interquartile range [IQR]: 21.6-44.9) than SDs (55.3 years, IQR: 32.8-70.4; P < .001) and more likely to have sustained a prior shoulder fracture (n = 11 [21.2%] vs. n = 3 [1.8%], P < .001). There were no differences in sex, laterality, or follow-up duration. Eighteen RDs (34.0%) and 18 SDs (10.7%) underwent surgery, including shoulder stabilization procedures, rotator cuff repairs, and fracture fixation (P < .001). RDs used significantly more opioids at the first follow-up in both the prescribed number of opioids (mean 0.23 ± 0.5 prescriptions vs. 0.10 ± 0.3, P = .038) and MME (mean 38.3 ± 96.2 MME vs. 10.7 ± 66.4 MME, P = .013). This difference is not appreciated from the 30-day postoperative visit onward. Emergency room opioid MME prescription and consumption was similar between cohorts.
CONCLUSION: Patients who sustain recurrent shoulder dislocations exhibit a higher likelihood of consuming significantly greater amounts of opioids following shoulder reduction and ultimately undergoing surgical intervention. The proportion of opioid tolerance and prereduction total MME up to 90 days prior to reduction in the RD cohort trended toward significance, but there were no differences observed between rates of opioid usage during ED encounters or at the 30-, 60-, and 90-day time points. Patients with chronic shoulder instability should be counseled regarding the increased risk of opioid prescription patterns in the immediate postreduction period; however, this risk may decrease over time.